Presented at 9th ACEDB CON 2025 · All posters from this congress
Endocrinology & DiabetologyOpen accessPoster communication · 2026-0064

From Growth failure to Gait failure: Arnold-Chiari 1 malformation in a teenager

Satya Prasad Koirala1✉, Md. Rafayel Islam1, Hurjahan Banu1, Nusrat Sultana1, Sharmin Jahan1, M A Hasanat1

  1. 1 Department of Endocrinology, Bangladesh medical University, Dhaka-Bangladesh

Received 17 November 2026 · Accepted 17 November 2026 · Published 17 November 2026

DOI: https://doi.org/10.5281/zenodo.24321948

Article PDF

views
40
downloads
12
countries
6

Since publication · journal site and Zenodo archive · robots excluded

Key messages

  1. Arnold-Chiari type I malformation can cause growth failure and delayed puberty due to hypothalamic-pituitary axis involvement.
  2. Early recognition of endocrine abnormalities in CM-I is critical for optimizing patient outcomes.
  3. Multidisciplinary management is essential for accurate diagnosis and prevention of long-term complications.

Abstract

Introduction

Arnold-Chiari type I malformation (CM-I) is a congenital anomaly of the craniovertebral junction characterized by caudal herniation of the cerebellar tonsils through the foramen magnum. It is classically associated with occipital headache, ataxia, and pyramidal tract signs, but its association with endocrine dysfunction remains underrecognized. Growth retardation and pubertal delay, although uncommon, may occur due to hypothalamic-pituitary axis involvement secondary to chronic intracranial pressure alterations or brainstem compression. Early recognition of endocrine manifestations in CM-I is critical for optimizing patient outcomes.

Materials and methods

A 17-year-old male, third child of non-consanguineous parents, presented with progressive growth failure for 6–8 years and difficulty walking for 4 years. Growth retardation became evident at 10 years despite normal appetite and school performance. Symptoms included chronic occipital headaches, blurred vision, intermittent dizziness, and progressive gait disturbance. Examination revealed disproportionate short stature (height 147 cm, arm span 161 cm, SDS -2.6), round facial features, scanty facial hair, under-pitched voice, delayed puberty (Tanner stage P2), left testicular volume 10 ml, right undescended testis palpable in inguinal region, dysarthria, tongue wasting with fasciculations, bilateral nystagmus, exaggerated deep tendon reflexes, extensor plantar responses, ankle clonus, and wide-based ataxic gait. Biochemical evaluation confirmed growth hormone deficiency; other pituitary hormones were normal. MRI showed foramen magnum stenosis, cervicomedullary compression, and dysplastic occipital condyles consistent with CM-1.

Results

Radiological bone age was 12-14 years, not corresponding with chronological age. Hormonal tests showed low TSH (1.17 mIU/L), normal FT4 (13 pmol/L), testosterone 7.71 nmol/L, ACTH 22 pg/ml, serum cortisol 317.6 nmol/L, FSH 4.27 U/L, LH 2.64 U/L. GnRH stimulation test showed LH increase from 2.64 to 26.83 mIU/ml. Short synacthen test showed basal cortisol 317.6 nmol/L and post-stimulation cortisol 1287 nmol/L. Growth hormone stimulation test showed basal GH 1.07 ng/ml and post-stimulation GH 3.41 ng/ml. IGF-1 was 250 ng/ml. MRI of pituitary and cervical spine confirmed structural abnormalities consistent with CM-1.

Conclusion

CM-I typically presents with neurological manifestations; endocrine abnormalities are rare but important. Growth hormone deficiency and delayed puberty may result from hypothalamic-pituitary axis dysfunction secondary to cervicomedullary compression and disrupted CSF dynamics. Coexistence of short stature and delayed puberty highlights potential endocrine implications of structural brain anomalies. Early recognition of CM-I in patients with unexplained growth failure and neurological features is crucial. A multidisciplinary approach ensures accurate diagnosis, timely intervention, and prevention of long-term neuroendocrine sequelae.

Original poster

References

  1. Rachinger J, Ferner FA, Stieglbauer K, et al. Hypothalamic-pituitary dysfunction in patients with Chiari I malformation. J Clin Endocrinol Metab. 2011;97(5):1541-1548.
  2. Chen Y, RS, Gordon OS, et al. Chiari malformations and their association with endocrinopathies: A review. Childs Nerv Syst. 2011;27(9):1541-1548.
  3. Shim YS, Lee HS, Kim MS, et al. Growth hormone deficiency associated with Chiari I malformation: Clinical features and outcomes.
Keywords
Arnold-Chiari malformation · growth failure · delayed puberty · endocrine dysfunction · hypothalamic-pituitary axis
Received
17 November 2026
Accepted
17 November 2026
Published
17 November 2026
Peer review
Single-anonymized review by the Editorial Board · How we review
DOI
https://doi.org/10.5281/zenodo.24321948
License
© The Authors 2026. Distributed under CC BY 4.0
Journal
MP Journal of Medical Research · ISSN 3144-8402

Related posters